Cargando…
Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c
The vaccine Mycobacterium bovis Bacillus Calmette-Guérin (BCG) elicits an immune response that is protective against certain forms of tuberculosis (TB); however, because BCG efficacy is limited it is important to identify alternative TB vaccine candidates. Recently, the BCG deletion mutant and vacci...
Autores principales: | Gunasena, Manuja, Shukla, Rajni Kant, Yao, Naiquan, Rosas Mejia, Oscar, Powell, Michael D., Oestreich, Kenneth J., Aceves-Sánchez, Michel de Jesús, Flores-Valdez, Mario Alberto, Liyanage, Namal P. M., Robinson, Richard T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300728/ https://www.ncbi.nlm.nih.gov/pubmed/35858977 http://dx.doi.org/10.1038/s41598-022-14935-y |
Ejemplares similares
-
Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
por: Aceves-Sánchez, Michel de Jesús, et al.
Publicado: (2021) -
Genome sequences of BCG Pasteur ATCC 35734 and its derivative, the vaccine candidate BCGΔBCG1419c
por: D’Auria, Giuseppe, et al.
Publicado: (2023) -
The BCGΔBCG1419c Vaccine Candidate Reduces Lung Pathology, IL-6, TNF-α, and IL-10 During Chronic TB Infection
por: Flores-Valdez, Mario A., et al.
Publicado: (2018) -
BCGΔBCG1419c increased memory CD8(+) T cell-associated immunogenicity and mitigated pulmonary inflammation compared with BCG in a model of chronic tuberculosis
por: Kwon, Kee Woong, et al.
Publicado: (2022) -
BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines
por: Segura-Cerda, Cristian Alfredo, et al.
Publicado: (2020)